Literature DB >> 12417056

Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline-deficient diet.

Claudia P M S Oliveira1, L Carlos da Costa Gayotto, Caroline Tatai, Bianca Ishimoto Della Bina, M Janiszewski, E S Lima, Dulcinéia S P Abdalla, F P Lopasso, F R M Laurindo, A A Laudanna.   

Abstract

BACKGROUND/AIM: The pathogenesis of Nonalcoholic Fatty Liver Disease remains largely unknown, but oxidative stress seems to be involved. The aim of this study was to evaluate the role of oxidative stress in experimental hepatic steatosis induced by a choline-deficient diet.
METHODS: Fatty liver disease was induced in Wistar rats by a choline-deficient diet. The animals were randomized into three groups: I (G1) and II (G2), n=6 each--fed with a choline-deficient diet for four and twelve weeks respectively; Group III (control-G3; n=6)--fed with a standard diet for twelve weeks. Samples of plasma and liver were submitted to biochemical, histological and oxidative stress analysis. Variables measured included serum levels of aminotransferases (AST, ALT), cholesterol and triglycerides. Oxidative stress was measured by lucigenin-enhanced luminescence and the concentration of hydroperoxides (CE-OOH-cholesteryl ester) in the liver tissue.
RESULTS: We observed moderate macro- and microvesicular fatty change in periportal zones G1 and G2 as compared to controls (G3). In G2, fatty change was more severe. The inflammatory infiltrate was scanty and no fibrosis was seen in any group. There was a significant increase of AST and triglycerides in G1 and G2 as compared to control group G3. The lucigenin-amplified luminescence (cpm/mg/min x 10(3)) was significantly increased in G1 (1393-/+790) and G2 (7191-/+500) as compared to controls (513-/+170), p<0.05. The concentrations of CE-OOH were higher in G1 (5.7-/+0.9 nmol/mg protein) as compared to control (2.6-/+0.7 nmol/mg protein), p<0.05.
CONCLUSION: 1) Oxidative stress was found to be increased in experimental liver steatosis; 2) The production of reactive oxygen species was accentuated when liver steatosis was more severe; 3) The alterations produced by oxidative stress could be an important step in the pathogenesis of nonalcoholic fatty liver disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417056      PMCID: PMC6740072          DOI: 10.1111/j.1582-4934.2002.tb00518.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  36 in total

Review 1.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Noninvasive Diagnosis of NASH and Liver Fibrosis Within the Spectrum of NAFLD.

Authors:  Naim Alkhouri; Arthur J McCullough
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-10

3.  Curcumin prevents liver fat accumulation and serum fetuin-A increase in rats fed a high-fat diet.

Authors:  Yildiz Öner-İyidoğan; Hikmet Koçak; Muhammed Seyidhanoğlu; Figen Gürdöl; Ahmet Gülçubuk; Funda Yildirim; Aydin Çevik; Müjdat Uysal
Journal:  J Physiol Biochem       Date:  2013-02-22       Impact factor: 4.158

4.  Thymoquinone alleviates nonalcoholic fatty liver disease in rats via suppression of oxidative stress, inflammation, apoptosis.

Authors:  Azza S M Awad; Ekram N Abd Al Haleem; Wesam M El-Bakly; Mohie A Sherief
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-01-12       Impact factor: 3.000

5.  c9,t11-Conjugated linoleic acid ameliorates steatosis by modulating mitochondrial uncoupling and Nrf2 pathway.

Authors:  Maria Pina Mollica; Giovanna Trinchese; Gina Cavaliere; Chiara De Filippo; Ennio Cocca; Marcello Gaita; Antonio Della-Gatta; Angela Marano; Giuseppe Mazzarella; Paolo Bergamo
Journal:  J Lipid Res       Date:  2014-03-15       Impact factor: 5.922

6.  Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.

Authors:  Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2015-01-28       Impact factor: 7.527

Review 7.  Mitochondria and redox signaling in steatohepatitis.

Authors:  E Matthew Morris; R Scott Rector; John P Thyfault; Jamal A Ibdah
Journal:  Antioxid Redox Signal       Date:  2011-04-26       Impact factor: 8.401

8.  OxNASH score correlates with histologic features and severity of nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Michael Berk; Lisa Yerian; Rocio Lopez; Yoon-Mi Chung; Renliang Zhang; Thomas M McIntyre; Ariel E Feldstein; Stanley L Hazen
Journal:  Dig Dis Sci       Date:  2014-01-25       Impact factor: 3.199

Review 9.  Noninvasive diagnosis of nonalcoholic fatty liver disease: Are we there yet?

Authors:  Naim Alkhouri; Ariel E Feldstein
Journal:  Metabolism       Date:  2016-02-02       Impact factor: 8.694

10.  Blood F2-isoprostanes are significantly associated with abnormalities of lipid status in rats with steatosis.

Authors:  Man-Jie Zhu; Li-Juan Sun; Yue-Qin Liu; Yan-Ling Feng; Hai-Tao Tong; Ying-He Hu; Zheng Zhao
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.